MARKET

U.S. stock futures flat as Trump and Iran trade threats against civilian infrastructure

U.S. stock-index futures bounced between slight losses and gains on Sunday night, as new threats of escalation from both President Donald Trump and Iran threatened

MARKET

Super Micro co-founder engaged in backdoor scheme to divert Nvidia chips to China, U.S. government says

Shares of Super Micro fall, though the company itself was not named in the federal indictment that charged Wally Liaw and two others Source link

MARKET

This biotech is working on a GLP-1 pill that could be better than the Wegovy version

This experimental pill helped people lose about 16% of their body weight after about a year of treatment Source link

MARKET

This little-known energy company’s stock is rallying as Trump invokes 1950 powers for offshore California drilling

Trump’s executive order opens the door for Sable Offshore’s production in Southern California. Source link

MARKET

Obamacare enrollment is plunging as costs soar, pushing down stocks like Centene

Americans are opting out of the Affordable Care Act, and health insurance companies are taking a financial hit. Source link

MARKET

How to step back from your job without killing your career

Many workers are looking to take a breather from their job or to scale back their high-stress career without quitting altogether. It can be done.

MARKET

Anthropic’s Claude tops App Store charts as backlash builds against OpenAI’s ChatGPT

OpenAI faces some user criticism over its new deal with the Department of Defense. Source link

MARKET

Yes, consumers in China are consuming again. It’s just not their No. 1 priority these days.

Retail sales are still rising, but record household savings, stepped-up gold buying and reined-in income expectations suggest the population of the world’s second largest economy

MARKET

Hims & Hers’ expansion plans — as well as its Super Bowl ad — have investors worried about profits

The wellness platform’s results arrived amid heightened legal and regulatory scrutiny over its weight-loss-drug business. Source link